1. Home
  2. CASS vs CGEM Comparison

CASS vs CGEM Comparison

Compare CASS & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASS
  • CGEM
  • Stock Information
  • Founded
  • CASS 1906
  • CGEM 2016
  • Country
  • CASS United States
  • CGEM United States
  • Employees
  • CASS N/A
  • CGEM N/A
  • Industry
  • CASS Business Services
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASS Consumer Discretionary
  • CGEM Health Care
  • Exchange
  • CASS Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • CASS 503.5M
  • CGEM 437.2M
  • IPO Year
  • CASS 1996
  • CGEM 2021
  • Fundamental
  • Price
  • CASS $41.19
  • CGEM $8.63
  • Analyst Decision
  • CASS Buy
  • CGEM Strong Buy
  • Analyst Count
  • CASS 2
  • CGEM 7
  • Target Price
  • CASS $45.50
  • CGEM $26.00
  • AVG Volume (30 Days)
  • CASS 106.4K
  • CGEM 848.8K
  • Earning Date
  • CASS 10-23-2025
  • CGEM 11-06-2025
  • Dividend Yield
  • CASS 3.10%
  • CGEM N/A
  • EPS Growth
  • CASS 37.29
  • CGEM N/A
  • EPS
  • CASS 2.31
  • CGEM N/A
  • Revenue
  • CASS $222,318,000.00
  • CGEM N/A
  • Revenue This Year
  • CASS N/A
  • CGEM N/A
  • Revenue Next Year
  • CASS $7.33
  • CGEM N/A
  • P/E Ratio
  • CASS $20.36
  • CGEM N/A
  • Revenue Growth
  • CASS 7.50
  • CGEM N/A
  • 52 Week Low
  • CASS $36.08
  • CGEM $5.68
  • 52 Week High
  • CASS $47.00
  • CGEM $16.20
  • Technical
  • Relative Strength Index (RSI)
  • CASS 60.87
  • CGEM 59.63
  • Support Level
  • CASS $39.06
  • CGEM $7.25
  • Resistance Level
  • CASS $42.07
  • CGEM $8.49
  • Average True Range (ATR)
  • CASS 1.02
  • CGEM 0.69
  • MACD
  • CASS 0.31
  • CGEM 0.03
  • Stochastic Oscillator
  • CASS 77.50
  • CGEM 86.48

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment, which provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: